Water → HCID 71239723, compound
Reaction equation
[NH2:1][C:2]1[N:7]=[C:6]([C:8]2[NH:12][C:11]([C:13]3[CH:18]=[C:17]([Cl:19])[CH:16]=[CH:15][C:14]=3[CH2:20][CH3:21])=[C:10]([C:22]([O:24][CH2:25][CH3:26])=[O:23])[CH:9]=2)[CH:5]=[CH:4][N:3]=1.[Br:27]N1C(=O)CCC1=O.O>CN(C=O)C>[NH2:1][C:2]1[N:7]=[C:6]([C:8]2[NH:12][C:11]([C:13]3[CH:18]=[C:17]([Cl:19])[CH:16]=[CH:15][C:14]=3[CH2:20][CH3:21])=[C:10]([C:22]([O:24][CH2:25][CH3:26])=[O:23])[CH:9]=2)[C:5]([Br:27])=[CH:4][N:3]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Ethyl 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-1H-pyrrole-3-carboxylate (450 mg, 1.21 mmol) in DMF (7.5 mL) was treated with N-bromosuccinimide (216 mg, 1.21 mmol). The mixture was stirred overnight at room temperature, then poured into water, extracted with EtOAc (2×30 mL). The separated organic phase was dried over sodium sulfate and the solvent evaporated. Crystallization from diethyl ether afforded the title compound (420 mg, 77%).
Workup
- extractionextracted with EtOAc (2×30 mL)
- dry with materialThe separated organic phase was dried over sodium sulfate
- customthe solvent evaporated
- customCrystallization from diethyl ether
Sources & evidence
- ORD record
- ord-6d54d44adbe2472582000dd9f924d2b1
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08912200B2
Reaction notes
Loading…